Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
10970232 | Vaccine | 2010 | 4 Pages |
Abstract
Mean serum binding and neutralizing antibody titers of hMPV infected subjects were significantly lower compared to uninfected subjects. Seventy-one percent of subjects with titers â¤10.5 (log 2) were infected compared to 36% with titers >10.5, p = 0.003. There was no difference in the mean acute antibody titers for patients with mild compared to severe illness. Serum antibody may play a role in protection from hMPV infection supporting the development of an hMPV vaccine that stimulates humoral immunity.
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
Ann R. Falsey, Patricia A. Hennessey, Maria A. Formica, Mary M. Criddle, Jamie M. Biear, Edward E. Walsh,